NeoGenomics, Inc.
DE ˙ DB ˙ US64049M2098
€ 9,61 ↑0.99 (11.51%)
2026-06-05
PREÇO DA AÇÃO
SecurityDE:NG9 / NeoGenomics, Inc.
InstitutionFmr Llc
Latest Disclosed Ownership226,313 shares
Latest Disclosed Value $ 1,679,241
Fmr Llc reports 32.75% increase in ownership of NG9 / NeoGenomics, Inc.

On May 15, 2026 - Fmr Llc filed a 13F-HR form disclosing ownership of 226,313 shares of NeoGenomics, Inc. (DE:NG9) valued at $1,425,772 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 170,487 shares of NeoGenomics, Inc.. This represents a change in shares of 32.75% during the quarter. The current value of the position is $2,175,321 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F NEOGENOMICS COM NEW 64049M209 226,313 55,826 32.75 1,679 -16.22 0.0000
2026-02-17 2025-12-31 13F NEOGENOMICS COM NEW 64049M209 170,487 133,359 359.19 2,005 600.70 0.0001
2025-11-13 2025-09-30 13F NEOGENOMICS COM NEW 64049M209 37,128 -117,243 -75.95 287 -74.65 0.0000
2025-08-14 2025-06-30 13F NEOGENOMICS COM NEW 64049M209 154,371 146,106 1,767.77 1,128 1,346.15 0.0001
2025-05-12 2025-03-31 13F NEOGENOMICS COM NEW 64049M209 8,265 -17,548 -67.98 78 -81.65 0.0000
2025-02-13 2024-12-31 13F NEOGENOMICS COM NEW 64049M209 25,813 12,558 94.74 425 117.95 0.0000
2024-11-13 2024-09-30 13F NEOGENOMICS COM NEW 64049M209 13,255 931 7.55 196 14.71 0.0000
2024-08-13 2024-06-30 13F NEOGENOMICS COM NEW 64049M209 12,324 -2,892 -19.01 171 -28.87 0.0000
2024-05-13 2024-03-31 13F NEOGENOMICS COM NEW 64049M209 15,216 663 4.56 239 1.70 0.0000
2024-02-13 2023-12-31 13F NEOGENOMICS COM NEW 64049M209 14,553 6,441 79.40 235 137.37 0.0000
2023-11-13 2023-09-30 13F NEOGENOMICS COM NEW 64049M209 8,112 -459 -5.36 100 -27.74 0.0000
2023-08-11 2023-06-30 13F NEOGENOMICS COM NEW 64049M209 8,571 -728 -7.83 138 -14.91 0.0000
2023-08-11 2023-03-31 13F/A-1 NEOGENOMICS COM NEW 64049M209 9,299 1,403 17.77 162 123.61 0.0000
2023-05-11 2023-03-31 13F NEOGENOMICS COM NEW 64049M209 9,299 1,403 162 0.0000
2023-02-13 2022-12-31 13F NEOGENOMICS COM NEW 64049M209 7,896 -6,345 -44.55 73 -40.98 0.0000
2022-11-10 2022-09-30 13F NEOGENOMICS COM NEW 64049M209 14,241 3,520 32.83 122 38.64 0.0000
2022-08-12 2022-06-30 13F NEOGENOMICS COM NEW 64049M209 10,721 8,497 382.06 88 225.93 0.0000
2022-05-13 2022-03-31 13F NEOGENOMICS COM NEW 64049M209 2,224 337 17.86 27 -58.46 0.0000
2022-02-14 2021-12-31 13F NEOGENOMICS COM NEW 64049M209 1,887 -178 -8.62 65 -34.34 0.0000
2022-02-14 2021-09-30 13F/A-1 NEOGENOMICS COM NEW 64049M209 2,065 973 89.10 99 102.04 0.0000
2021-11-15 2021-09-30 13F NEOGENOMICS COM NEW 64049M209 2,065 973 99 0.0000
2021-08-13 2021-06-30 13F NEOGENOMICS COM NEW 64049M209 1,092 42 4.00 49 -3.92 0.0000
2021-05-14 2021-03-31 13F NEOGENOMICS COM NEW 64049M209 1,050 -362 -25.64 51 -32.89 0.0000
2021-02-08 2020-12-31 13F NEOGENOMICS COM NEW 64049M209 1,412 -931 -39.74 76 -11.63 0.0000
2020-11-13 2020-09-30 13F NEOGENOMICS COM NEW 64049M209 2,343 1,114 90.64 86 126.32 0.0000
2020-08-24 2020-06-30 13F/A-1 NEOGENOMICS COM NEW 64049M209 1,229 262 27.09 38 40.74 0.0000
2020-08-13 2020-06-30 13F NEOGENOMICS COM NEW 64049M209 1,229 262 38 0.9335
2020-05-14 2020-03-31 13F NEOGENOMICS COM NEW 64049M209 967 -37 -3.69 27 -10.00 0.0000
2020-02-07 2019-12-31 13F NEOGENOMICS COM NEW 64049M209 1,004 -124,182 -99.20 30 -98.75 0.0000
2019-11-13 2019-09-30 13F NEOGENOMICS COM NEW 64049M209 125,186 123,837 9,179.91 2,393 8,151.72 0.0003
2019-08-13 2019-06-30 13F NEOGENOMICS COM NEW 64049M209 1,349 1,302 2,770.21 29 2,800.00 0.0000
2019-05-13 2019-03-31 13F NEOGENOMICS COM NEW 64049M209 47 47 1 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.